On November 26, 2024, ysb announced that it has completed the acquisition of approximately 85.64% of the issued and outstanding share capital of the target company. As part of the acquisition consideration, ysb has issued and allocated a total of 31,678,555 consideration shares to the seller and its nominees. This acquisition involves multiple sellers, including the founder seller GD Venture Ltd., Paul Sprint Ltd., and JFC Venture Ltd., as well as investor sellers like Cenova China Healthcare Fund V, L.P.Before the issuance of consideration shares, the total number of issued shares of ysb was 644,080,446 shares; after the issuance, the total increased to 675,759,001 shares. The completion of this acquisition marks an important step for ysb in expanding its business territory. The company will...Show More

On November 26, 2024, ysb announced that it has completed the acquisition of approximately 85.64% of the issued and outstanding share capital of the target company. As part of the acquisition consideration, ysb has issued and allocated a total of 31,678,555 consideration shares to the seller and its nominees. This acquisition involves multiple sellers, including the founder seller GD Venture Ltd., Paul Sprint Ltd., and JFC Venture Ltd., as well as investor sellers like Cenova China Healthcare Fund V, L.P.Before the issuance of consideration shares, the total number of issued shares of ysb was 644,080,446 shares; after the issuance, the total increased to 675,759,001 shares. The completion of this acquisition marks an important step for ysb in expanding its business territory. The company will timely make further announcements regarding the acquisition and reminds shareholders and potential investors to exercise caution when buying and selling company shares.The board of directors is led by the chairman and executive director Mr. Zhang Buzhen, with members including executive director Mr. Chen Fei, non-executive director Mr. Zhu Ziyang, and independent non-executive directors Ms. Shao Rong, Mr. Sun Hanhui, and Mr. Zhao Hongqiang.